Clinical efficacy study of Meryton syrup on Menorrhagia
Phase 2
Completed
- Conditions
- Health Condition 1: N920- Excessive and frequent menstruation with regular cycle
- Registration Number
- CTRI/2019/08/020571
- Lead Sponsor
- Vasu Research Centre VRC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 61
Inclusion Criteria
Patients with menstrual cycle between 21-35 days with bleeding morein volume and for 7 days,with BMI between 18-30kg/m2.
Exclusion Criteria
Patients sufferinfg from kidney,liver or cardiac disease
Patients having genitic problem,anotomical defect of reproductive organs
Patients suffering from dysmenorrhoea, PID
Patients under hormonal treatement
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcomes will be normalization of menstrual cycles and hormonal levels.Timepoint: 3 months
- Secondary Outcome Measures
Name Time Method Assessment of drug safety, patient compliance and patientâ??s quality of lifeTimepoint: 1 month